Physician profile
Brian E Schwartz
NPI 1104116151
$54,309.98
in general payments reported to CMS, 2019-2025
17 companies · $19K in 2025
The $19K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2021: $341 · 2022: $271 · 2023: $11K · 2024: $13K · 2025: $19K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $40K · Food and Beverage: $1,385 · Travel and Lodging: $576 · Education: $33.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,322.88 |
| Food and Beverage | $1,384.52 |
| Travel and Lodging | $576.49 |
| Education | $33.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $36,093.83 | 2023-2025 | |
| Medacta USA, INC. | $10,628.74 | 2019-2025 | Amistem |
| Medical Device Business Services, INC. | $5,986.21 | 2019-2023 | Attune |
| Depuy Synthes Sales INC. | $548.04 | 2019-2021 | |
| Smith+Nephew, INC. | $274.45 | 2022-2025 | Real Intelligence, Journey II |
| Medtronic USA, INC. | $121.34 | 2019 | |
| Argentum Medical | $107.12 | 2021 | |
| Omnilife Science, INC | $101.96 | 2022 | |
| Pixee Medical INC. | $100.00 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $98.12 | 2024-2025 | Exparel, Zilretta |
| Bone Support INC. | $95.12 | 2025 | Cerament G, Ceramentbone Void Filler |
| Curonix LLC | $49.20 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ferring Pharmaceuticals INC. | $35.59 | 2023-2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $33.79 | 2025 | |
| Horizon Therapeutics Plc | $12.87 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.18 | 2019 | |
| Next Science LLC | $11.42 | 2023 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Schwartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.